Every earnings call for ALIVUS — management tone, guidance, KPIs and promise tracking, quarter by quarter.
ALIVUS · 7 transcripts · Healthcare · latest Q4 FY26Alivus Life has 7 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue (Q4 FY26) ₹689 cr (+6% YoY); EBITDA (Q4 FY26) ₹237 cr (+14% YoY); EBITDA Margin (Q4 FY26) 34.4%. Full year FY26 revenue at INR2,552 crores, up 6.9% YoY.
Read full transcript & analysisRevenue ₹673 cr (+5% YoY); EBITDA Margin 36.4%; PAT ₹150 cr. Reported highest ever quarterly revenue of ₹673 crores, up 14.4% QoQ and 4.8% YoY.
Read full transcript & analysisRevenue (Q3 FY26) ₹673 cr (+5% YoY); EBITDA (Q3 FY26) ₹245 cr (+22% YoY); EBITDA Margin (Q3 FY26) 36.4%. Revenue from operations stood at ₹673 crores, a growth of 14.4% QoQ and 4.8% YoY.
Read full transcript & analysisRevenue ₹602 cr (+2% YoY); EBITDA Margin 30.1%; PAT ₹122 cr. Revenue reported at ₹602 crores, representing a 2.2% YoY growth.
Read full transcript & analysisRevenue ₹650 cr (+21% YoY); EBITDA Margin 32.1%; PAT ₹142 cr. Q4 Revenue reached ₹650 crores, representing a strong 21.1% YoY growth and 1.2% QoQ growth.
Read full transcript & analysisRevenue ₹642 cr (+12% YoY); EBITDA Margin 31.3% (+1% YoY); PAT ₹137 cr. Revenue of ₹642 crores, representing 12% YoY growth and 26.6% QoQ recovery.
Read full transcript & analysisRevenue ₹507 cr (−15% YoY); EBITDA Margin 28.2%; PAT ₹95 cr. Revenue from operations at ₹507 crores, down 14.9% YoY and 13.9% QoQ.
Read full transcript & analysis